ProCyte Contributes Its TiSilc Sun Protection Product At The
ProCyte Contributes Its TiSilc Sun Protection Product At The Entertaining Liza
Benefit
REDMOND, Wash., June 14 /PRNewswire/ -- ProCyte Corporation
(OTC Bulletin Board: PRCY), a leading skin care and tissue repair company,
announced today that its TiSilc(TM) Advanced Sun Protection product was
presented as a key note gift to attendees of Liza Minnelli's "Entertaining
Liza" benefit for Recording Artists, Actors, and Athletes Against Drunk
Driving held on June 7, 1999.
The product's unique safety coated, micronized titanium, silicon and
vitamin rich formula is a favorite of dermatologists and plastic surgeons for
use with their patients. Offering both UVA and UVB protection, TiSilc(TM)
helps prevent sun damage, which is associated with premature aging and skin
cancer. The popular product is in an elegant, tinted lotion base, and is
easily applied.
In this era of consumer demand for sun protection products, more than 90%
of dermatologists recommend sunscreens for their patients. The importance of
daily UVA/UVB protection has become a critical healthcare issue. A recent
report by the National Cancer Institute noted that generally overall cancer
rates were dropping, except in the area of skin cancer.
"Sun protection products are a huge market for men, women and children,"
said ProCyte President and CEO, Jack Clifford. "TiSilc is recommended by
leading dermatologists and plastic surgeon's due to its reputation as a
superior sunscreen and the company's reputation for innovative technologies."
"Sun protection is a must for our clients," said Lana Stone, Director of
Solutions Skin Care in Beverly Hills. "Our customers love TiSilc's elegant
formulation, so we know that they will use the product on a daily basis."
About ProCyte:
In addition to TiSilc(TM), ProCyte's product portfolio includes
comprehensive skin care lines for therapeutic care, pigmentation concerns,
anti-aging product and products for thinning hair. ProCyte Corporation is a
healthcare products company that develops, manufactures and markets products
for tissue repair, skin health and hair care. The Company's products
incorporate its patented copper peptide technology and are marketed both
directly and through distribution partners.
This report may contain forward-looking statements. The Company's results
may vary significantly from quarter to quarter and will depend among other
factors on product launches and market acceptance, manufacturing contracts,
and distribution agreements.
Contact: Jack Clifford, President/CEO of ProCyte Corporation,
425-869-1239; or Michael S. Manahan, Principal of Magnum Financial Group, LLC,
213-488-0443, for ProCyte Corporation.
SOURCE ProCyte Corporation
-0- 06/14/99
/CONTACT: Jack Clifford, President/CEO of ProCyte Corporation,
425-869-1239; or Michael S. Manahan, Principal of Magnum Financial Group, LLC,
213-488-0443, for ProCyte Corporation/
/Web site: procyte.com
(PRCY)
|
